Case Presentation
=================

We present the case of a 30-year-old primigravida, who visited the outpatient clinic of "Alexandra" Maternity Hospital in Athens, Greece. Her past medical history was uneventful. The first-trimester ultrasound scan performed at 13 weeks of gestation revealed increased placental thickness for the gestational age (above the 95 ^th^ percentile) (Karthikeyan et al., 2012). Closer examination of the placenta revealed numerous anechoic cystic lesions. Doppler examination did not reveal the presence of blood flow within the placental lesions. The fetal anatomy was normal, the nuchal translucency was 1.7 mm and the amniotic fluid was within normal range. The appearance of the placenta on ultrasound combined with the presence of a live fetus could be attributed to partial molar pregnancy, mesenchymal placental dysplasia, Beckwith Wiedemann syndrome or multiple hematomas. The free β hCG was 33.77 IU/L (0.83 MoM) and the serum PAPP-A was 3.790IU/L (1.587 ΜοΜ). Genetic counseling was advised, followed by amniocentesis, array-based comparative genomic hybridization (aCGH) and methylation-specific multiple ligation probe amplification analysis (MS-MLPA) for epigenetic changes associated with Beckwith Wiedemann syndrome. aCGH showed a normal female karyotype and MS-MLPA was negative for Beckwith Wiedemann Syndrome. The second-trimester anomaly scan was normal, with the exception of marginal bilateral renal pelvis dilation (5.3 and 5.5 mm, respectively). The placental area with the multiple cystic lesions was 10.53×4.66×7.35 cm and color Doppler still revealed no vascular flow ( [Fig. 1](#FI0190-0001){ref-type="fig"} ). 3D ultrasonography revealed multiple small vesicles in the uterine cavity, originating from the placenta ( [Fig. 2](#FI0190-0002){ref-type="fig"} ). During the routine ultrasound scan in the 32 ^nd^ week of gestation, growth arrest was detected. The estimated fetal weight, calculated via the Hadlock formula, dropped from the 42 ^nd^ to the 15 ^th^ percentile. The patient was admitted to the high-risk pregnancy unit and induction of labor was decided at 36 weeks of gestation. The woman gave birth to a healthy girl that weighed 2210 gr and had an Apgar score of 9 in the first minute and 10 in the 5 ^th^ . The placenta weighed 720 gr, which is over the normal limit for the gestational age. Pathology examination of the placenta confirmed the diagnosis of placental mesenchymal dysplasia ( [Fig. 3](#FI0190-0003){ref-type="fig"} ).

![Placental mesenchymal dysplasia at 21 weeksof gestation. The placental area with the multiple cystic lesions measured 10.53×4.66×7.35 cm. Color Doppler revealed the absence of vascular flow.](10-1055-a-1180-9571-i0190-0001){#FI0190-0001}

![3D ultrasonography revealed multiple small vesicles in the uterine cavity.](10-1055-a-1180-9571-i0190-0002){#FI0190-0002}

![( **a b** ) Histology revealed markedly edematous stem villi, thick-walled vessels and a lack of trophoblastic proliferation.](10-1055-a-1180-9571-i0190-0003){#FI0190-0003}

Discussion
==========

Despite the rarity of MSD, the presence of a normal appearing fetus on three-dimensional sonography along with a thick placenta with multiple cystic lesions with low or absent vascular flow on color Doppler evaluation point in the direction of PMD.

When PMD is included in the differential diagnosis, it is essential to rule out partial molar pregnancy, since the management varies greatly. Hence, invasive prenatal testing (chorionic villus sampling or amniocentesis) is required to evaluate the fetal karyotype (Vaisbuch et al., 2009). Further management includes MS-MLPA analysis to exclude Beckwith-Wiedemann Syndrome.

Antenatal genetic counselling is essential as placental mesenchymal dysplasia has been associated with diverse perinatal outcomes, ranging from uneventful delivery of a healthy neonate to significant maternal and infant morbidity. Both parents and clinicians must keep in mind that PMD has been associated with vaginal bleeding, preterm delivery (33%), fetal anomalies (such as liver cysts and vascular malformations), fetal growth restriction (33%), stillbirth (13%) and Beckwith-Wiedemann syndrome (omphalocele, macroglossia, macrosomia, organomegaly) (Matsui et al., 2003; Nayeri et al., 2013). Incidental discovery of PMD in pregnancies with normal perinatal outcomes has also been described (9%) (Nayeri et al., 2013).

Pregnancies with suspicious sonographic findings should be monitored closely, due to the increased risk of adverse perinatal outcomes. In the third trimester intense supervision along with consecutive growth scans and evaluation of fetal wellness are recommended to ensure the delivery of a healthy infant. After delivery the placenta should be sent for pathological assessment to verify PMD (Nayeri et al., 2013).

**Conflict of Interest** The authors declare that they have no conflict of interest.
